Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more
Yuyu Pharma Inc (000227) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.006x
Based on the latest financial reports, Yuyu Pharma Inc (000227) has a cash flow conversion efficiency ratio of 0.006x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million) by net assets (₩139.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
0.140x |
|
Adyton Resources Corporation
PINK:ADYRF
|
0.004x |
|
Arena Group Holdings Inc
NYSE MKT:AREN
|
-1.170x |
|
Crown Confectionery Co Ltd
KO:264900
|
-0.003x |
|
Malaysian Bulk Carriers Bhd
KLSE:5077
|
0.000x |
|
CIFI Holdings (Group) Co. Ltd
F:6CI
|
0.064x |
|
Ebebek Magazacilik Anonim Sirketi
IS:EBEBK
|
0.354x |
|
ELUON Corporation
KQ:065440
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩135.06 Billion | ₩24.95 Billion | 0.185x | +5182.83% |
| 2023-12-31 | ₩120.36 Billion | ₩420.86 Million | 0.003x | +106.93% |
| 2022-12-31 | ₩123.37 Billion | ₩-6.23 Billion | -0.050x | -244.10% |
| 2021-12-31 | ₩128.69 Billion | ₩4.51 Billion | 0.035x | +253.64% |
| 2020-12-31 | ₩117.04 Billion | ₩-2.67 Billion | -0.023x | -115.66% |
| 2019-12-31 | ₩90.54 Billion | ₩13.19 Billion | 0.146x | +107.05% |
| 2018-12-31 | ₩86.87 Billion | ₩6.11 Billion | 0.070x | +937.85% |
| 2017-12-31 | ₩82.83 Billion | ₩561.35 Million | 0.007x | -94.60% |
| 2016-12-31 | ₩78.29 Billion | ₩9.82 Billion | 0.125x | +179.12% |
| 2015-12-31 | ₩73.73 Billion | ₩-11.68 Billion | -0.158x | -930.90% |
| 2014-12-31 | ₩71.49 Billion | ₩1.36 Billion | 0.019x | -- |